Beyond this specific isoform, though, it appears splicing as a whole may be dysregulated in the lesion microenvironment given the drastic increase in EDC4 labeling in MS lesions, as a single isoform is not likely to have such a profound impact. The gene discussed is EDC4; the disease is myeloid sarcoma.